1. Home
  2. CE vs RGEN Comparison

CE vs RGEN Comparison

Compare CE & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celanese Corporation

CE

Celanese Corporation

HOLD

Current Price

$65.29

Market Cap

7.1B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$131.49

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CE
RGEN
Founded
1918
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.6B
IPO Year
2004
1995

Fundamental Metrics

Financial Performance
Metric
CE
RGEN
Price
$65.29
$131.49
Analyst Decision
Buy
Buy
Analyst Count
14
12
Target Price
$63.00
$167.67
AVG Volume (30 Days)
2.2M
749.1K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
0.19%
N/A
EPS Growth
23.62
286.96
EPS
N/A
0.86
Revenue
$9,544,000,000.00
$141,236,000.00
Revenue This Year
$3.14
$14.30
Revenue Next Year
$2.83
$14.52
P/E Ratio
N/A
$153.93
Revenue Growth
N/A
35.10
52 Week Low
$35.13
$109.66
52 Week High
$68.77
$175.77

Technical Indicators

Market Signals
Indicator
CE
RGEN
Relative Strength Index (RSI) 56.10 61.43
Support Level $37.64 $130.40
Resistance Level $67.82 $131.93
Average True Range (ATR) 2.94 4.94
MACD -0.37 2.14
Stochastic Oscillator 65.15 64.10

Price Performance

Historical Comparison
CE
RGEN

About CE Celanese Corporation

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: